5 Innovative Public Policy to Prevent HAIs

Friday, April 1, 2011: 5:00 PM-7:00 PM
Chantilly Ballroom (Hilton Anatole)
CME Credits: 2
Type: Plenary Sessions
Summary: Public policy approaches to preventing HAIs have evolved rapidly in the past five years, moving beyond mandates for public reporting and pathogen-specific surveillance. Government, business, and healthcare stakeholders are driving policy innovations in payment/reimbursement, quality improvement and measurement, and behavior change and implementation. This session outlines key policy initiatives of a primary policy actor – CMS – and efforts to evaluate the impact of those policies and measure progress toward preventing HAIs. Attendees will also learn about the important policy perspectives and contributions from the field of healthcare epidemiology, that are represented by SHEA.
Learning Objectives:
Endorsed by:
  • American Hospital Association
  • Center for Disease Control and Prevention
  • Extending the Cure Project of the Center for Disease Dynamics, Economics & Policy
  • Infusion Nurses Society
  • Pediatric Infectious Diseases Society
Moderators:
Steven M. Gordon, MD , Russell N. Olmstead, MPH, CIC and Tammy Lundstrom, MD, JD

5:00 PM
18A
The Future of the Centers for Medicare and Medicaid Services (CMS) in Driving HAI Prevention
Joseph McCannon, AB, Centers for Medicare & Medicaid Services
5:30 PM
18B
Lessons from Public Health: Toward HAI Elimination, Cost Reduction and Health Improvement
Chesley Richards, MD, Center for Disease Control and Prevention
6:00 PM
19
Defining the Research Agenda that Informs Policy and Measures Its Impact
Patricia W. Stone, RN, PhD, MPH, Columbia University School of Nursing
6:30 PM
20
Science Leads: SHEA's Role in Driving Public Policy on HAI Prevention
Patrick J. Brennan, MD, University of Pennsylvania Health System